Evidence map›Paper›PMID 34206613›Full record

ArticleInternational journal of molecular sciences2021

Combined Naïve Bayesian, Chemical Fingerprints and Molecular Docking Classifiers to Model and Predict Androgen Receptor Binding Data for Environmentally- and Health-Sensitive Substances.

Alfonso T García-Sosa, Uko Maran

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.8field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Molecules (Basel, Switzerland) · 2023
    Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Alfonso T García-SosaInstitute of Chemistry, University of Tartu, Ravila 14a, 50411 Tartu, Estonia.ORCID 0000-0003-0542-4446
Uko MaranInstitute of Chemistry, University of Tartu, Ravila 14a, 50411 Tartu, Estonia.
University of Tartu · EE

Funding

Eesti Teadusagentuur IUT34-14Sihtasutus Archimedes TK143
6 · The paper itself

Abstract

Many chemicals that enter the environment, food chain, and the human body can disrupt androgen-dependent pathways and mimic hormones and therefore, may be responsible for multiple diseases from reproductive to tumor. Thus, modeling and predicting androgen receptor activity is an important area of research. The aim of the current study was to find a method or combination of methods to predict compounds that can bind to and/or disrupt the androgen receptor, and thereby guide decision making and further analysis. A stepwise procedure proceeded from analysis of protein structures from human, chimp, and rat, followed by docking and subsequent ligand, and statistics based techniques that improved classification gradually. The best methods used multivariate logistic regression of combinations of chimpanzee protein structural docking scores, extended connectivity fingerprints, and naïve Bayesians of known binders and non-binders. Combination or consensus methods included data from a variety of procedures to improve the final model accuracy.

Indexed as

Bayes TheoremMolecular Docking SimulationMolecular Dynamics SimulationEndocrine DisruptorsHumansLigandsLogistic ModelsMolecular StructureProtein BindingQuantitative Structure-Activity RelationshipReceptors, AndrogenReproducibility of ResultsROC CurveEndocrine DisruptorsLigandsReceptors, Androgenandrogen receptorbayesianchemical fingerprintschimpdockingecfphumanmultivariate logistic regressionrattoxicity

Identifiers

PMID34206613
PMCPMC8267747
OpenAlexW3176696948

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.